Acquired glucose sensitivity of k-ras transformed fibroblasts

F Chiaradonna1, C Magnani, E Sacco

  • 1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.

Insights

Mutational activation of the ras gene drives cancer. A dominant-negative Ras activator mutant reverted Ras-transformed cells to a wild-type phenotype, revealing cancer cell fragility.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Ras gene mutations are crucial drivers of malignant transformation.
  • Ras pathway activation significantly impacts cell proliferation and tumor formation.

Purpose of the Study:

  • To investigate the role of Ras pathway activation in cancer cell phenotype.
  • To explore the therapeutic potential of targeting Ras activators.

Main Methods:

  • Construction of a dominant-negative mutant (GEF-DN) of a Ras activator protein.
  • Over-expression of GEF-DN in k-ras transformed NIH 3T3 fibroblasts.
  • Assessment of cellular morphology, anchorage-independent growth, and tumor formation in nude mice.

Main Results:

  • GEF-DN over-expression reduced intracellular Ras*GTP levels.
  • Reversion of transformed NIH 3T3 fibroblasts to a wild-type phenotype.
  • Demonstrated dependence of NIH-ras cells on high glucose for proliferation.
  • Highlighted acquired metabolic fragility in cancer cells.

Conclusions:

  • Targeting Ras activator proteins can revert cancer cell phenotypes.
  • Ras-transformed cells exhibit heightened sensitivity to nutrient deprivation.
  • This metabolic vulnerability presents a potential therapeutic strategy for Ras-driven cancers.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...